OBJECTIVES: Over the past three decades, numerous studies have focused on the biological activities of oligomeric proanthocyanidins (OPCs) in the prevention of many diseases such as neurodegeneration, atherosclerosis, tumorigenesis, and microbial infections. OPC has redox-active metabolites which could modulate the intracellular redox equilibrium to maintain the antioxidant homeostasis. This redox-modulating efficiency of OPC could provide new insights into therapeutic approaches that could reduce the burden of cardiovascular diseases. The main objective of this study was to explore the biological and metabolic activities of OPC using in silico approaches.
Introduction
R ecent scientific reports emphasize numerous biological activities such as antioxidant, anti-inflammatory, a n t i c a r c i n o g e n i c , a n t i m i c r o b i a l , vasodilatory, and cardioprotective effects of flavonoids and polyphenols. [1] Oligomeric proanthocyanidins (OPCs) or condensed tannins, consisting of oligomers or polymeric forms of flavan-3-ols, are among the most abundant polyphenols present in all edible fruits and berries. The normal daily consumption of B-type proanthocyanidins varies from 10 mg to 500 mg/day. [2] Proanthocyanidins are known to possess antioxidant and radical scavenging activities. OPC has been shown to inhibit low-density lipoprotein oxidation, [3] induce platelet activation and function, [4] and possess anticarcinogenic activity, [5] mainly due to their complex structure and degree of polymerization. [6, 7] Clinical and experimental studies have shown that consumption of proanthocyanidins improves the antioxidant status and atherosclerotic plaque stability, prevents DNA damage, and possesses anticancer activity. [8] To validate the use of proanthocyanidins as a potential drug, its bioavailability and its efficiency in reaching the target tissue should be taken into consideration. Hence, it is important to gain an understanding about the absorption, distribution, metabolism, and excretion (ADME) of the OPCs. A recent study on proanthocyanidins showed that its degradation takes place in the stomach. It was reported that the strong acid in the stomach (pH 2-4) can degrade the oligomers into monomers and dimers. Few studies have emphasized that proanthocyanidins can be degraded by the colonic microflora which resulted in the production of aromatic acids. [9] Figure 1 illustrates the possible bioavailability of OPCs during oral administration.
Various approaches have been used to validate a potential candidate drug. Determination of ADME-toxicity (ADME-Tox) properties is an essential sequel of drug discovery. [10] The identification of metabolites and the modification of the compounds are essential to improve its pharmacokinetic properties. This has been achieved by predicting the possible site of metabolism (SOM) of compounds. In order to address this hypothesis, recent studies have used in silico methods to predict the SOM. [11, 12] These in silico approaches are broadly classified into two types namely, ligand-and structure-based approaches. Ligand-based models provide indirect information about the active site of a protein based on the shape, electronic properties, conformational changes of substrates, inhibitors, and metabolic products. [13, 14] The ligand-based model also predicts the metabolic fate of a compound depending on its chemical and structural characteristics. A structure-based method provides the substrate's properties, the specificity of interaction between the substrate and the enzyme, rationalization of metabolic reactions, structure elucidation, and computation of dynamics and reactivity of compounds. The combination of both ligand-and structure-based approaches becomes a more promising approach by its synergistic effects between different metabolic reactions. The objectives of this present study are to evaluate the metabolism, bioavailability, toxicity, and biological activity of OPC using different in silico approaches.
Methods

Ligand-based metabolism prediction SmartCYP
SmartCYP is a freeware to predict the sites of metabolism of a given compound, most commonly based on the cytochrome P450 (CYP) enzymes. In this study, we have predicted the CYP450-associated sites of epigallocatechin gallate, gallocatechin, gallocatechingallate, procyanidins, and proanthocyanidin molecules. SmartCYP tool accepts SDF format of the molecules and predicts the SOM by recognizing two-dimensional (2D) formats of the molecules and predicts the CYP450-mediated metabolic sites. This tool calculates the oxidation states of aliphatic carbons and aromatic sites by applying density functional theory. [15, 16] SmartCYP is freely available from the Internet at http://www.farma.ku.dk/smartcyp.
MetaPrint2D
MetaPrint2D is a new tool for predicting the sites of Phase I metabolism based on data-mining approaches of xenobiotic metabolism. This algorithm is based on the analysis of the prediction of atom center's circular fingerprints of both substrates and metabolites. [17] Metaprint2D can be freely accessed from the web platform (http://wwwmetaprint2d.ch.cam.ac. uk/metaprint2d/).
Chemical structures of potential metabolites
MetaPrint2D-React
MetaPrint2D-React is an extension of MetaPrint2D extending it from SOM prediction -prediction of the metabolic transformations and metabolites formed. MetaPrint2D-React is available from the Internet at http:// www-metaprint2d.ch.cam.ac.uk/metaprint2d-react. [18] This tool predicts different transformations (addition of oxygen, hydroxylation, oxidation, epoxidation, and elimination reaction) of molecules that can take place at the SOM where the likely metabolite is to be formed.
Toxicity prediction of potential metabolites Molinspiration
This online tool helps the end user to analyze the molecular description and druglikeliness properties of compounds (http://www.molinspiration.com). Molinspiration server works based on the Lipinski Rules of Five. [19] The most "drug-like" compound must possess the following properties: LogP ≤5, molecular weight ≤500Da, number of hydrogen bond acceptors ≤10, and number of hydrogen bond donors ≤5. Compounds that failed to show these characters are least considered as a drug. Molinspiration server calculates the important molecular properties of compounds based on partition coefficient (LogP), polar surface area, number of hydrogen bond donors and acceptors, and also prediction of bioactivity score for the drug targets such as G-Protein Coupled Receptor (GPCR) ligands, kinase and protease inhibitors (KIs and PIs), ion channel modulators (ICMs), and nuclear receptor ligand (NRL). Topographical polar surface area (TPSA) was used to calculate the percentage of absorption using the following equation: Percentage of absorbance = 109 − 0.345 × TPSA. [20] admetSAR predictions
The pharmacokinetic properties such as ADMET-Tox of the compounds can be predicted using admetSAR (http:// www.admetexp.org) database. [21] In admetSAR, web-based query tools incorporating a molecular build-in interface enable the database to be queried by SMILES and structural similarity search. It provides the latest and most comprehensive manually curated data for diverse chemicals associated with known ADMET profiles.
Biological activity spectrum (BAS)
Biologically activity spectrum (BAS) of a compound represents an intrinsic property of the pharmacological effects, physiological and biochemical mechanisms of action, and specific toxicity (mutagenicity, carcinogenicity, teratogenicity, and embryotoxicity), which is largely dependent on the interaction with the biological system. [22] The values vary from 0.000 to 1.000. Only those activity types for which Pa (probability to be active) > Pi (probability to be inactive) were considered possible (www.pharmaexpert.ru/passonline/index.php). Figure 2 shows the possible interaction of OPC with CYP450. From the results, the SOM at C1, C2, and C3 sites was predicted, and the ability of the OPC to activate/inhibit the cytochrome system was determined.
Results and Discussion
Figures 3 and 4 illustrate the SOM predicted by very accurate and efficient tools -Metaprint2D and
Metaprint2D react, respectively. Metaprint 2D analysis showed the SOM as follows: the atoms are colored according to the likelihood of a metabolic site. Red circle shows the sites with the highest oxidation reaction, yellow indicates medium, green represents low, and no color represents no likelihood of metabolism occurring at that particular site. The high normalized ratio denotes a more frequent SOM.
The Lipinski "rule of five" is commonly used as an index during drug design and development to predict the oral bioavailability of the lead drug molecules. Based on Lipinski's "rule of five," drug compound should satisfy the following criteria: (1) The molecular weight of the candidate drug should be >500, (2) LogP <5, and (3) More than 5 hydrogen bond donors (OH and NH groups), where hydrogen donor should be <10 (N and O). The predicted molecular properties of OPC using Molinspiration tool are represented in Table 1 . From the results obtained, epigallocatechin gallate, gallocatechin, and gallocatechin gallate parameters were within the Lipinski Rule of Five, whereas, procyanidins and proanthocyanidin showed increased molecular weight (<500). Moreover, other properties such as LogP, TPSA, and hydrogen donor and acceptor are within the range. Hence, all the compounds of OPC do not violate the Lipinski rule and could be expected to be orally active as they followed Lipinski Rule of Five. A high likelihood is shown in red, medium likelihood is shown in orange, low likelihood is shown in green, and very low likelihood is not colored. A high normalized ratio indicates a more frequently reported site of metabolism in the metabolite database for epigallocatechin, gallocatechin, gallocatechin gallate, proanthocyanidins, and procyanidins The bioactivity scores of OPC compounds were also predicted using Molinspiration tool and represented in Figure 5 . If a molecule is predicted to have a bioactivity score of >0.00, it is likely to demonstrate considerable biological activities, whereas the values −0.50-0.00 indicate moderately active molecules, and less that −0.50 is presumed to be inactive. From the results, it is obvious that the physiological actions of OPC could be due to the strong interactions with GPCR ligands, NRLs, and inhibition of proteases and other enzymes. These bioactivity scores obtained suggested that OPC compounds could interact with all the drug targets. All the compounds showed good bioactivity based on the scores obtained for all drug targets.
ADMET properties of compounds were calculated using admetSAR cheminformatics tool to predict the pharmacokinetic properties for the effectiveness and bioavailability of compounds. From Table 2 , it can be observed that ADMET properties of compounds specify threshold ADMET characteristics for the chemical structure of the molecules based on the available drug databases. The scores of human intestinal absorption (HIA) predict the intestinal absorption after oral administration. Then, the AlogP value and PSA scores of compounds show that they are well absorbed during absorption. The aqueous solubility (LogS) predicts the solubility properties of each compound in water at 25°C. From the results, it has been shown that all the compounds used in this study showed maximum solubility. An important ADMET parameter is blood-brain barrier (BBB), which predicts the bioactivity of drug to reduce neurological burden after oral administration. Among all compounds, procyanidin alone is positive for BBB, i.e., this compound is known to enter the CNS after oral administration. Whether a compound is likely to interact with the carrier proteins, which are available in the blood, is predicted from the plasma protein-binding model. CYP2D6 ADMET properties showed that constituents of OPC inhibit the enzyme CYP450. Finally, from the ADMET results, it was shown that the compounds did not exhibit toxicity. 
Discussion
To understand the biological activity of OPC, this study highlighted the bioavailability and pharmacokinetic properties using in silico approach to predict the possible SOM; biotransformation; Phase I metabolism; ADMET; and biological activities of the constituent compounds, such as epigallocatechin gallate, gallocatechin, gallocatechin gallate, procyanidins, and proanthocyanidins.
CYP450 plays a vital role in the metabolism of xenobiotics. During drug development, it is mandatory to study the metabolic reactions and toxicities. Hence, in this study, we used both structure-based and ligand-based tools to predict the SOM. The scores obtained from SMARTCyp tool for OPC compounds showed that compounds were properly undergoing metabolism in the liver. [23, 24] Results of Metaprint2D showed high metabolism rate for all the ligands and showed numerous biotransformation reactions such as alkylation, acylation, glucuronidation, sulfation, and methylation. Kim et al. [25] have reported an important secondary metabolite 5-(3',5'-dihydroxyphenyl)-γ-valerolactone (EGC-M5) of green tea catechins, which exerts important immunoregulatory effects. These kinds of biotransformed metabolites of compounds are responsible to elicit biological activities such as antioxidant and anti-inflammatory activities. [26] Thus, OPC produces secondary metabolites by conjugating with glucuronide and sulfate to form biologically active metabolites. Serra et al. [27] have also reported t h a t m e t a b o l i s m o f p r o c y a n i d i n s p r o d u c e s methyl-catechin-sulfate and phenolic acids. Studies reported that secondary metabolites such as phenolic acids and lactones from oligomers form through the fission of heterocyclic and A-rings. [28] The released metabolites are responsible to maintain plasma cholesterol homeostasis and inhibition of monocyte adhesion to the endothelial cells. [29] Molinspiration tool is very useful and accurate in predicting certain properties of the ligand to assess its efficacy and biological activity based on calculating, cLogp, number of hydrogen donors and acceptors, TPSA, and number of rotatable bonds present in the target ligand. From the results obtained, gallocatechin (molecular weight <500 Da) could easily be transported, diffused, and absorbed, whereas other ligands with high molecular weight (>500 Da) cannot. However, other ligands might be degraded into their respective monomers and dimers by the action of gut and colon microbiota which may increase their absorption rate.
Lipophilicity (LogP) and TPSA values determine the oral bioavailability of a drug. LogP values of all five ligands were within the range, showing that the rate of permeability into a cell for these ligands is considerable. Thereby, OPC could easily pass the phospholipid bilayer because of its lipophilic nature. TPSA is an important parameter which determines drug absorption, bioavailability, permeability, and penetration. This was calculated from the surface area of hydrogen bond between the O and N atoms. Results showed that all ligands exhibit TPSA and number of rotatable bonds with more than the predicted range. Hence, we emphasize that our ligand of interest showed increase in TPSA and rotatable bonds because it has more aromatic hydroxyl groups in its structure. The number of hydrogen donor and acceptor of a ligand determines the flexibility and adaptability of the ligand to bind with the target enzyme or protein. Specific biological activities of a ligand determine the drug likeliness property of ligands. As shown in Figure 4 , all ligands showed >0.000 values for GPCR ligands, ICM, KI, PI, and NRL. All ligands showed the suggested range of biological activities.
Whenever a xenobiotic is introduced into the system, CYP450 and its isoforms, which belong to a family of hemoproteins, play a vital role in drug metabolism and clearance. CYP450 catalyzes the Phase I metabolism which oxygenates lipophilic compounds into water-soluble forms. When a compound fails to activate the CYP450 system, drug molecules accumulate in the tissue, resulting in toxicity. All the ligands of this study showed positive results for HIA but negative results for BBB and Caco-2 cell permeability. They reported the antidiabetic effects of grape seed proanthocyanidins which cross the BBB. [30] All ligands showed no inhibitory side effects in terms of renal cation transport. This tool also analyzes the ability of the ligands to serve as a P-glycoprotein substrate. The results demonstrate that all the ligands showed positive results and were identified as noninhibitors of P-glycoproteins.
This study showed the prediction of toxicity profiles of all the ligands for mutagenicity, tumorigenicity, reproductive effectiveness, irritancy, human ether-a-go-go-related gene inhibition, Ames toxicity, carcinogenicity, fish toxicity, Tetrahymena pyriformis toxicity, honey bee toxicity, biodegradation, acute oral toxicity category, and acute rat toxicity. Table 2 shows the toxicity profiles for all the ligands. The toxicity profiles of the selected compounds revealed that most of the compounds were not mutagenic, carcinogenic, or tumorigenic. Similarly, the selected compounds were negative for Ames toxicity, were weak inhibitors of human ether-a-go-go-related genes, and exhibit no properties that exert significant toxicity in humans. On the contrary, all the selected compounds were found to present high toxicity for fish, T. pyriformis, and honey bees. Administration of OPC to animals showed beneficial effects by preventing hepatic and renal toxicities. [31] Stefanovic et al. [32] showed reduced levels of blood urea nitrogen and serum creatinine in experimentally induced myoglobinuric rats. OPC did not possess any known side effects, toxicity, or drug interactions.
The possible biological activities of all the ligands were obtained by using PASS server. The set of pharmacological effects, mechanisms of action, and specific toxicities, that might be exhibited by a compound in its interaction with biological entities, and which is predicted by PASS, is termed the BAS of this compound. The Pa (probability to be active) and Pi (probability to be inactive) values vary from 0 to 1, and Pa + Pi <1, since these probabilities are calculated independently. Pa and Pi are measures of the compound under study belonging to the classes of active and inactive compounds, respectively. From our results, all the ligands showed potent antioxidant and cardioprotective activities within the prescribed range. From the previous reports on OPC, promising cardioprotective and antioxidant activities in experimental animals were seen. Hence, these results using in silico tools strongly recommend that OPC could be a potent cardioprotective agent.
Conclusion
Taken together, all the compounds of OPC showed sites for CYP450 metabolism and Phase I metabolism and possible secondary metabolites of OPC. Thus, OPC could be a potent drug candidate by displaying its prescribed range of clogp value, number of rotatable bonds, number of hydrogen donor and acceptor, solubility, flexibility and adaptability. From the results, all ligands possess, G-Protein Coupled Receptor, ion channel modulator, kinase and protease inhibitor activity and nuclear receptor activity. OPC could be efficiently absorbed, distributed and metabolized. Toxicity studies on OPC revealed that none of the ligands used in this study showed any toxicity. OPC has potent cardioprotective and antioxidant properties as predicted. Hence, OPC may be postulated as a candidate drug for cardiovascular diseases.
